Trending Now
Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine Booster Under EU Review
Moderna Inc.’s (NASDAQ: MRNA) COVID-19 vaccine booster shot is under review by the EU regarding the possibility of administration after six months of the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapy treatments, is at...
MAKE IT MODERN
LATEST REVIEWS
InflaRX N.V. (NASDAQ: IFRX) Announce Encouraging Data From Cohort 3 of...
InflaRX N.V. (NASDAQ: IFRX) has announced positive findings from the third group of patients in the phase IIa open-label trial with vilobelimab in treating...
MAKE IT MODERN
PERFORMANCE TRAINING
Omeros Corporation (NASDAQ:OMER) Publishes Final Safety And Efficacy Data From Narsoplimab Stem Cell Transplantation...
Omeros Corporation (NASDAQ:OMER) recently disclosed its comprehensive final findings of its clinical trial evaluating narsoplimab’s performance in hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).
Narsoplimab...
Wall Street looks ready to invest in China’s reopening
Strategists predict that China's markets will deliver significant gains to investors this year, as the country's reopening has sparked renewed interest in...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) To Present XPOVIO® Clinical Data At 2020 ESMO
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has announced the selection of four abstracts for poster presentation at the 2020 virtual European Society for Medical Oncology Congress.
Karyopharm...
BioMarin Pharmaceuticals Inc. (NASDAQ:BMRN) Reports Net Revenue Of $460.7 Million In Q3 2020
BioMarin Pharmaceuticals Inc. (NASDAQ:BMRN) has announced its Q3 financial results for the quarter ended September 30, 2020, in which net product revenue was $460.7...
Pfizer Inc. (NYSE:PFE) And Sangamo Therapeutics Inc. (NASDAQ:SGMO) Announce Positive Results Of Their Gene...
Pfizer Inc. (NYSE:PFE) and Sangamo Therapeutics Inc. (NASDAQ:SGMO) have announced that their gene therapy was effective in maintaining Factor VIII inhibitors in patients with...
MAKE IT MODERN
